Skip to content

Detection and kinetics of IL-38 positive cells in induced sputum in atopic mild adult asthmatics after allergen challenge

Detection and kinetics of IL-38 positive cells in induced sputum in atopic mild adult asthmatics after allergen challenge - IL-38 positive cells in atopic asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000033420
Enrollment
60
Registered
2018-08-01
Start date
2018-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic mild adult asthma

Interventions

None listed

Sponsors

Department of medicine, Kurume University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. mild asthmatics and healthy non-smoking controls 2. Non-smokers 3. Stable for at least 4wks 4. %forced vital capacity >80% predicted, %forced expiratory volume in 1 sec, >80% predicted and a ratio FEV1/FVC >0.7

Exclusion criteria

Exclusion criteria: 1. Difficulty expectoration of induced sputum 2. Presence of any other moderate and severe comorbidities 3. Current or ex-smokers 4. participants who have judged that research directors and researchers are inappropriate as research subjects 5. Nursing and pregnancy

Design outcomes

Primary

MeasureTime frame
Primary endpoint is to investigate the correlation frequency of IL-38 positive cells per macrophage or monocytes in induced sputum and airway inflammation, hyperresponsiveness on methacholine, and asthmatic response after allergen challenge in atopic mild adult asthmatics.

Secondary

MeasureTime frame
Secondary endpoint is investigate the correlation frequency of IL-38 positive cells per macrophage or monocytes in induced sputum and peripheral blood in atopic mild adult asthmatics. We investigate whether frequency of IL-38 positive cells per macrophage or monocytes induced sputum and peripheral blood will be able to usefulness to evaluate the pathogenesis and severity of asthma as a biomarker.

Countries

Japan

Contacts

Public ContactTomotaka Kawayama

Kurume University Department of medicine

kawayama_tomotaka@med.kurume-u.ac.jp0942-31-7560

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026